Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies

• Published in: Journal of translational medicine Vol. 22; no. 1; pp. 837 - 31
• Main Authors: Shi, Zhuangzhuang, Li, Zhaoming, Zhang, Mingzhi
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 11-09-2024; BioMed Central; BMC
• Subjects: Analysis; Animals; Biomarker; Cancer; Carcinogenesis - pathology; Care and treatment; Composition; Diagnosis; Epigenetic inheritance; Genetic aspects; Humans; Immunotherapy; Intratumor microbiota; Microbiota; Microbiota (Symbiotic organisms); Neoplasms - microbiology; Neoplasms - therapy; Patient outcomes; Personalized cancer therapy; Review; Tumorigenesis; China; Personalized cancer therapy; Biomarker; Intratumor microbiota; Tumorigenesis; Immunotherapy; Cancer
• ISSN: 1479-5876; 1479-5876
• DOI: 10.1186/s12967-024-05640-7

The intricate interplay between the host and its microbiota has garnered increasing attention in the past decade. Specifically, the emerging recognition of microorganisms within diverse cancer tissues, previously presumed sterile, has ignited a resurgence of enthusiasm and research endeavors. Four potential migratory routes have been identified as the sources of intratumoral microbial "dark matter," including direct invasion of mucosal barriers, spreading from normal adjacent tissue, hematogenous spread, and lymphatic drainage, which contribute to the highly heterogeneous features of intratumor microbiota. Importantly, multitudes of studies delineated the roles of intratumor microbiota in cancer initiation and progression, elucidating underlying mechanisms such as genetic alterations, epigenetic modifications, immune dysfunctions, activating oncogenic pathways, and inducing metastasis. With the deepening understanding of intratumoral microbial composition, novel microbiota-based strategies for early cancer diagnosis and prognostic stratification continue to emerge. Furthermore, intratumor microbiota exerts significant influence on the efficacy of cancer therapeutics, particularly immunotherapy, making it an enticing target for intervention in cancer treatment. In this review, we present a comprehensive discussion of the current understanding pertaining to the developmental history, heterogeneous profiles, underlying originations, and carcinogenic mechanisms of intratumor microbiota, and uncover its potential predictive and intervention values, as well as several inevitable challenges as a target for personalized cancer management strategies.